Physician profile
Christopher Chiodo
NPI 1457318875
$539,041.90
in general payments reported to CMS, 2019-2025
8 companies · $76K in 2025
The $76K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $73K · 2021: $64K · 2022: $80K · 2023: $83K · 2024: $78K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $237K · Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $236,595.23 |
| Food and Beverage | $277.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $271,242.90 | 2019-2025 | Trabecular Metal |
| Arthrex, INC. | $212,526.08 | 2019-2025 | Arthrex |
| Djo, LLC | $53,707.85 | 2019-2025 | Aircast, Procare |
| Kairos Surgical INC | $1,291.66 | 2019-2020 | |
| Treace Medical Concepts, INC. | $198.96 | 2023-2025 | |
| Smith+Nephew, INC. | $43.41 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System |
| Medshape, INC. | $16.56 | 2023 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Orthofix Medical, INC. | $14.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chiodo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.